Compare PCRX & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | UVSP |
|---|---|---|
| Founded | 2006 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 910.5M |
| IPO Year | 2011 | 1989 |
| Metric | PCRX | UVSP |
|---|---|---|
| Price | $26.23 | $34.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $32.86 | ★ $33.00 |
| AVG Volume (30 Days) | ★ 723.2K | 141.6K |
| Earning Date | 11-06-2025 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.52% |
| EPS Growth | N/A | ★ 19.65 |
| EPS | 0.47 | ★ 2.98 |
| Revenue | ★ $716,791,000.00 | $309,144,000.00 |
| Revenue This Year | $6.24 | $12.98 |
| Revenue Next Year | $9.53 | $3.02 |
| P/E Ratio | $55.78 | ★ $11.71 |
| Revenue Growth | 3.14 | ★ 7.22 |
| 52 Week Low | $18.17 | $22.83 |
| 52 Week High | $27.64 | $35.65 |
| Indicator | PCRX | UVSP |
|---|---|---|
| Relative Strength Index (RSI) | 67.86 | 70.03 |
| Support Level | $25.17 | $34.20 |
| Resistance Level | $24.81 | $35.65 |
| Average True Range (ATR) | 0.96 | 0.85 |
| MACD | 0.26 | 0.18 |
| Stochastic Oscillator | 76.49 | 77.62 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.